Vilin Bio Med IPO Peer Comparison
Vilin Bio Med Limited peer comparison with similar listed entities. () (As on March 31, 2022)
| Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) |
|---|
| EPS Basic |
|---|
| Vilin Bio Med Limited | 0.04 | 8.96 | 294.82 | 0.45 |
| JFL Life Sciences Limited | 3.77 | 42.66 | 10.82 | 25.20 |
| Vaishali Pharma Limited | 3.82 | 24.99 | 33.77 | 15.27 |
| Anuh Pharma Limited | 6.10 | 6.10 | 14.70 | 14.30 |
Notes:
- Vilin Bio Med Limited's financial information is derived from our Restated Financial Information for the year ended March 31, 2022.
- All the financial information for listed industry peers mentioned above is sourced from the regulatory filings made by aforesaid companies to stock exchanges for the year ended March 31, 2022, to compute the corresponding financial ratios. Except for JFL Life Sciences Limited, which is as on February 28, 2022, derived from Final Prospectus dated August 11, 2022.
- P/E figures for the peers are based on closing market prices of equity shares on BSE on June 6, 2023, divided by the EPS in the table above.
- Basic Earnings per share = Net profit after tax, as restated attributable to equity shareholders /Weighted average number of shares outstanding during the year/ period.
- NAV per share for listed industry peers is computed as the Total Equity as on March 31, 2022, divided by the outstanding number of equity shares as on March 31, 2022.
- Return on Net Worth (%) for listed industry peers has been computed based on the Profit for the year ended March 31, 2022, divided by Total Equity as on March 31, 2022.
